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Voiding Dysfunction
Is Increased Prostatic Urethral Angle Related to Lower Urinary 
Tract Symptoms in Males with Benign Prostatic Hyperplasia/Lower 
Urinary Tract Symptoms?
Yoo Jun Park, Kwon Ho Bae, Byung Soo Jin, Hyun Jin Jung, Jae Shin Park
Department of Urology, Catholic University of Daegu, School of Medicine, Daegu, Korea
Purpose: The prostatic urethra is a bent tube, and the clinical significance of the pro-
static urethral angle (PUA) was recently reported. We investigated the statistical sig-
nificance of an increased PUA on the International Prostate Symptom Score (IPSS) in 
men with benign prostatic hyperplasia (BPH)/lower urinary tract symptom (LUTS). 
Materials and Methods: A retrospective analysis was done of 270 men with BPH/LUTS 
from July 2009 to June 2011. Prostate volume, PUA, and intravesical prostatic pro-
trusion (IPP) were measured by transrectal ultrasonography (TRUS). The IPSS was 
analyzed separately as storage and voiding symptom score. In order to minimize the 
effect of prostate size on voiding, patients with prostate size over 40 ml were excluded.
Results: The mean age was 62.0±9.3 years. The mean prostate volume was 29.0±5.5
ml (range, 20 to 40 ml), and median PUA and IPP were 34
o (range, 12 to 52
o) and 1.7 
mm (range, 0 to 5.3 mm), respectively. The mean IPSS, mean IPSS-ss, and mean 
IPSS-vs were 19.0±8.2, 7.3±4.0, and 11.6±5.5, respectively. The prostate volume had 
no statistically significant correlation with IPSS, IPSS-ss, or IPSS-vs. IPP had a stat-
istically significant correlation with IPSS (p＜0.001), IPSS-ss (p＜0.001), and IPSS-vs 
(p＜0.001). PUA had no statistically significant correlation with IPSS or IPSS-ss. 
However, PUA had a significant correlation with IPSS-vs (p=0.047). Comparing a high-
er PUA (≥34
o) with a lower PUA (＜34
o), patients with a higher PUA had a higher IPSS 
(p=0.001) and a higher IPSS-vs (p=0.001). There was no significant difference in 
IPSS-ss, prostate volume, or PSA between the two groups.
Conclusions: IPP showed significantly correlated with the IPSS and voiding symptom 
score was affected by the PUA but not by the prostate volume. As the PUA increased, 
the patients' voiding symptoms worsened. Further study may be needed. 
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INTRODUCTION
Benign prostatic hyperplasia (BPH) is one of the most com-
mon problems faced by aging men and can be associated 
with bothersome lower urinary tract symptoms (LUTS). It 
is well known that BPH can affect quality of life by interfer-
ing with normal daily activities and sleep patterns. 
Currently, evaluation for the treatment of BPH includes 
digital rectal examination, the International Prostate 
Symptom Score (IPSS), serum prostate-specific antigen 
levels (PSA), and uroflowmetry with postvoid residual 
urine (PVR). Urodynamic study and transrectal ultra-
sonography (TRUS) are done in special circumstances [1]. 
Several studies have reported the importance of anatom-
ical factors in evaluating men with BPH. One of these is a 
recently reported hypothesis stating that because the pro-
static urethra is a bent tube, the prostatic urethral angle 
(PUA) may be a causal factor for BPH pathogenesis and Korean J Urol 2012;53:410-413
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FIG. 1. (A) Prostatic urethral angle 
measured by TRUS shows 56
o. (B) Int-
ravesical prostatic protrusion measu-
red by TRUS shows 53 mm.
TABLE 1. p-values between factors according to Pearson's 
correlation in 270 men
 Factor p-value r
Age (yr), mean±SD
IPSS-total
IPSS-ss
IPSS-vs
62.0±9.3
＜0.001
＜0.001
＜0.001
0.553
0.595
0.457
r=correlation coefficients.
IPSS-ss, International Prostate Symptom Score- storage symp-
toms; IPSS-vs, International Prostate Symptom Score- voiding 
symptoms.
LUTS [2,3]. Also, the IPSS, which was originally developed 
by the World Health Organization (WHO), has been widely 
adopted and used as a reliable method for detecting and cat-
egorizing the severity of LUTS. 
In the present study, we investigated whether an in-
creased PUA significantly affects the IPSS in men with 
BPH. 
MATERIALS AND METHODS
Retrospective analysis was done from July 2009 to June 
2011 of 270 men with BPH. These patients underwent a de-
tailed clinical evaluation including a medical history, digi-
tal rectal examination, IPSS, frequency-volume chart, uri-
nalysis, PSA, uroflowmetry with PVR, and TRUS. Prostate 
volume, PUA, and IPP were measured on the image find-
ings of TRUS. PUA was calculated on the midsagittal plane 
of the prostate as described in a previous report and was 
recorded from 0 to 90
o (Fig. 1A) [3]. IPP was measured as 
the shortest distance between the protruded end of the 
prostate and the bladder base on the bladder neck in the 
sagittal plane, which reflects the maximum longitudinal 
length of the prostate as suggested by Nose et al. [4] (Fig. 
1B).
The IPSS was recorded and separated as the storage 
symptom (IPSS-ss) and voiding symptom (IPSS-vs) 
subscores. Patients with a urologic tumor, neurogenic 
bladder, urinary tract infection, or bladder stones, which 
could affect voiding, were excluded. To minimize the effect 
of prostate size on voiding symptoms, patients with a pros-
tate size of over 40 ml were excluded. We used SPSS ver. 
13.0 (SPSS Inc., Chicago, IL, USA) for statistical analysis, 
and multiple linear regression analysis and Pearson’s cor-
relation were used to analyze the relationship of the 
factors. p-values of ＜0.05 were considered statistically 
significant.
RESULTS
The patients’ mean age was 62.0±9.3 years. Their mean 
prostate volume was 29.0±5.5 ml (range, 20 to 40 ml), and 
the median PUA and IPP were 34
o (range, 12 to 52
o) and 
1.7 mm (range, 0 to 5.3 mm), respectively. The mean IPSS, 
IPSS-ss, and IPSS-vs were 19.0±8.2, 7.3±4.0, and 11.6±5.5, 
respectively.
The prostate volume had no statistically significant cor-
relation with IPSS, IPSS-ss, or IPSS-vs. Age and IPP were 
significantly correlated with IPSS (p＜0.001), IPSS-ss (p
＜0.001), and IPSS-vs (p＜0.001). PUA had no statistically 
significant correlation with IPSS or IPSS-ss. However, 
PUA was significantly correlated with IPSS-vs (p=0.047) 
(Table 1). 
According to the results of the multiple linear regression 
analysis, IPSS-total, IPSS-ss, and IPSS-vs were sig-
nificantly associated with age. Whereas IPP was sig-
nificantly associated with IPSS-total and IPSS-ss, PUA 
was significantly associated with IPSS-vs (Table 2).
Comparing a higher PUA (≥34
o) with a lower PUA 
(＜34
o), patients with a higher PUA had a higher IPSS 
(p=0.001) and a higher IPSS-vs (p=0.001). There was no 
significant difference in IPP, IPSS-ss, prostate volume, or 
PSA between the two groups (Table 3).
DISCUSSION
It is known that the prevalence of histopathologic BPH is 
age dependent [5]. Usually, histopathologic BPH begins to 
develop after the age of 40 years, and the prevalence be-
comes greater than 50% by the age of 60 years and as high 
as 90% by the age of 85 years. Despite its high prevalence, 
however, the pathogenesis of BPH is still poorly understood.
BPH is bothersome to patients when it is combined with Korean J Urol 2012;53:410-413
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TABLE 3. Comparison of factors according to the prostatic urethral angle (PUA)
Mean
PUA ＜34
o PUA ≥34
o p-value
Number
Age (yr)
Prostate-specific antigen (ng/ml)
Transrectal ultrasonography 
Total prostate volume (ml)
Intravesical prostatic protrusion
International Prostate Symptom Score
Storage symptoms
Voiding symptoms
Total score
Quality of life index
133
62.3±8.6
  1.4±1.1
28.6±5.4
  1.5±0.8
  6.7±3.6
11.7±5.1
18.3±7.1
  3.6±0.9
137
  62.6±10.4
  1.4±1.3
28.5±5.7
  1.7±0.7
  7.5±3.6
13.7±4.4
21.2±6.9
  3.8±0.8
0.775
0.831
0.833
0.187
0.061
0.001
0.001
0.091
TABLE 2. p-values between factors according to multivariate 
linear regression analysis in 270 men
Age 
(62.0±9.3 yr)
a
PV 
(29.0±5.5 ml)
a
IPP 
(1.7 mm)
b
PUA
(34
o)
b
IPSS-total
IPSS-ss
IPSS-vs
0
0
0
0.194
0.413
0.283
0.001
0.043
0.212
0.061
0.208
0.001
PV, prostate volume; IPP, intravesical prostatic protrusion; PUA, 
prostatic urethral angle; IPSS-ss, International Prostate 
Symptom Score-storage symptoms; IPSS-vs, International 
Prostate Symptom Score-voiding symptoms. 
a:Mean value, 
b:Median value.
LUTS. Urodynamic study has been helpful for assessing 
men with bothersome LUTS suggestive of BPH. However, 
its invasive nature and potential complications have lim-
ited routine clinical application [6,7]. Several recent stud-
ies have reported the importance of anatomical factors in 
evaluating LUTS suggestive of BPH. TRUS is a relatively 
noninvasive study that could be used on an outpatient clin-
ic basis to evaluate the anatomical structure of the 
prostate. One of the anatomical factors in BPH evaluation 
is IPP. 
IPP is a morphological change by which the prostate pro-
trudes into the bladder during the process of prostatic 
enlargement. It is induced by the enlargement of the lateral 
and median lobes, which leads to the ball-valve type of blad-
der outlet obstruction (BOO) and abnormal movement of 
the bladder as a result of inhibition of the funnel effect of 
the bladder neck at urination [8,9]. Chia et al. [10] de-
scribed that strong bladder contraction opens the channel 
between the lateral lobes but accelerates the ball-valve ef-
fect by IPP, which induces more BOO than does the en-
largement of the lateral lobe or the prostatic enlargement 
alone.
Whereas IPP is caused by the protrusion of the middle 
lobe components into the bladder neck, an increased PUA 
may be the result of a higher bladder neck in men who have 
no lateral or median prostatic lobe enlargement [3]. 
Although some urologists suspect that the higher bladder 
neck might be a causal factor of BPH, the clinical sig-
nificance of PUA is not well understood.
The prostatic urethra runs through the prostate from the 
base to the apex, making an anterior angulation of 35
o at 
the proximal part of the verumontanum. This bend divides 
the urethra into the proximal and distal portions [11].
Cho et al. [3] demonstrated that PUA is inversely asso-
ciated with maximal flow rate (Qmax). In the study by Cho 
et al. [3], patients were healthy men (aged 50 to 59 years, 
prostate volume 30 ml, and Qmax 15 ml/s) who had no evi-
dence of BOO. By applying fluid dynamics to the process 
of urination in the prostatic urethra, Cho et al. [3] sug-
gested that energy loss in the bending tube in the prostatic 
urethra could occur during micturition. They insisted that 
because the increased energy loss resulting from PUA 
leads to a decrease in urine velocity, the urine flow rate is 
inversely associated with PUA [2]. Ku et al. [12] found that 
PUA is correlated with the BOO index. As PUA increases, 
the BOO index increases. Patients with PUA ≥  35
o were 
more likely to have equivocal or outlet obstruction than 
were those with PUA ＜  35
o.
There have been several reports about the relationship 
between the IPSS and IPP [13-15]. However, despite the 
published study regarding the relationship between PUA 
and urinary flow rates, there are few reports about the rela-
tionship between the IPSS and PUA.
The IPSS was developed by the WHO and has been wide-
ly adopted as a reliable method of detecting and categoriz-
ing the severity of LUTS. The IPSS consists of seven items, 
each of which is rated from 0 (not at all) to 5 (almost all the 
time). The total score is the sum of the seven items and 
therefore has a range of from 0 to 35. The greater the score, 
the more severe the symptoms. The IPSS categorizes pa-
tients into three symptom groups: mild, 0-7; moderate, 
8-18; and severe, ＞18.
In the present study, IPP had a statistically significant 
correlation with the IPSS (p＜0.001), IPSS-ss (p＜0.001), 
and IPSS-vs (p＜0.001). We found that PUA correlated Korean J Urol 2012;53:410-413
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with only the IPSS-vs (p=0.047) in patients with LUTS or 
BPH. Multivariate linear regression analysis also showed 
a statistically significant relation between PUA and the 
IPSS-vs (p=0.001). We found no correlations between PUA 
and the IPSS or IPSS-ss. When we compared patients with 
higher a PUA with patients with a lower PUA, patients 
with a higher PUA were more likely to have a higher voiding 
symptom score (p=0.001). This agrees with the concept of 
PUA being a cause of BOO. Further study to investigate the 
relationship between PUA and LUTS or BPH may be 
needed.
CONCLUSIONS
The results of our study showed that IPP was significantly 
correlated with the IPSS and that the voiding symptom 
score was affected by the PUA but not by the prostate 
volume. As the PUA increased, the patients' voiding symp-
toms worsened. Further study may be needed. 
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